NextCure Management
Management criteria checks 3/4
NextCure's CEO is Michael Richman, appointed in Oct 2015, has a tenure of 8.5 years. total yearly compensation is $1.72M, comprised of 31.9% salary and 68.1% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth €532.93K. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.
Key information
Michael Richman
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 31.9% |
| CEO tenure | 8.5yrs |
| CEO ownership | 1.4% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$63m |
| Sep 30 2023 | n/a | n/a | -US$66m |
| Jun 30 2023 | n/a | n/a | -US$70m |
| Mar 31 2023 | n/a | n/a | -US$70m |
| Dec 31 2022 | US$2m | US$549k | -US$75m |
| Sep 30 2022 | n/a | n/a | -US$74m |
| Jun 30 2022 | n/a | n/a | -US$73m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$529k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$68m |
| Jun 30 2021 | n/a | n/a | -US$66m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$6m | US$491k | -US$37m |
| Sep 30 2020 | n/a | n/a | -US$32m |
| Jun 30 2020 | n/a | n/a | -US$24m |
| Mar 31 2020 | n/a | n/a | -US$18m |
| Dec 31 2019 | US$626k | US$419k | -US$34m |
| Sep 30 2019 | n/a | n/a | -US$30m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$24m |
| Dec 31 2018 | US$3m | US$383k | -US$23m |
Compensation vs Market: Michael's total compensation ($USD1.72M) is above average for companies of similar size in the German market ($USD406.04K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Richman (62 yo)
8.5yrs
Tenure
US$1,724,186
Compensation
Mr. Michael S. Richman, MSBA, Co-founded NextCure, Inc. since 2015 and has been its Chief Executive Officer, President & Director since July 2015. Mr. Richman served as the Chief Executive Officer and Pres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.5yrs | US$1.72m | 1.42% $ 532.9k | |
| Chief Scientific Officer | 5.3yrs | US$990.52k | 0.13% $ 50.2k | |
| Chief Medical Officer | 3.3yrs | US$953.32k | 0% $ 0 | |
| Co-Founder & Chairman of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Chief Financial Officer | 6.3yrs | US$1.01m | no data | |
| Chief Operating Officer | 4.5yrs | no data | no data | |
| General Counsel | 1.9yrs | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data | |
| Senior Vice President of Development & Manufacturing | 2.8yrs | no data | no data | |
| Senior Vice President of Business Development | less than a year | no data | no data | |
| Senior Vice President of Clinical & Translational Development | less than a year | no data | no data |
3.3yrs
Average Tenure
62.5yo
Average Age
Experienced Management: 2US's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.5yrs | US$1.72m | 1.42% $ 532.9k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.3yrs | US$94.17k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 8.3yrs | US$122.67k | 0.22% $ 83.7k | |
| Independent Director | 5yrs | US$101.17k | 0% $ 0 | |
| Independent Director | 8.3yrs | US$96.17k | 0% $ 0 | |
| Independent Director | 2.5yrs | US$91.17k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.6yrs | US$91.17k | 0% $ 0 | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
| Independent Director | 2.5yrs | US$90.17k | 0% $ 0 |
5.0yrs
Average Tenure
64yo
Average Age
Experienced Board: 2US's board of directors are considered experienced (5 years average tenure).